Approved! FDA Grants IND Clearance to Three More Candidates Today

The U.S. Food and Drug Administration (FDA) is on a roll granting approvals. Three companies announced Investigational New Drug (IND) application updates today.

Organicell – COPD Drug

Miami-based Organicell has been in the news recently with drug candidate Zofin, which saw its IND approved last May for the treatment of COVID-19 patients. The drug is now knee-deep in four different COVID trials, according to the company’s website, after which they plan to pursue an accelerated pathway to a Biologics License Application (BLA) for the drug in COVID patients.